TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ARQT

Arcutis Biotherapeutics Inc

Healthcare · Biotechnology

26.40$ -5.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARQT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.00 0.00 0.00 0.00 0.00 0.07 0.86 1.62 2.96
– – 0.01 0.01 0.02 0.01 0.07 0.16 0.29
– – -0.01 -0.01 -0.02 0.05 0.79 1.47 2.67
3.23 0.50 0.96 3.23 2.95 3.32 1.60 0.63 0.61
0.66 0.05 0.17 0.60 1.23 2.22 2.50 1.84 2.16
3.89 0.54 1.13 3.82 4.18 5.53 4.27 2.53 2.76
-3.89 -0.54 -1.13 -3.83 -4.18 -5.48 -3.48 -1.06 -0.10
0.00 0.00 0.00 0.00 0.01 0.28 0.43 0.22 0.09
-4.71 -0.53 -1.10 -3.80 -4.18 -5.66 -3.74 -1.15 -0.12
-3.89 -0.01 0.00 0.00 -0.01 0.18 0.04 0.01 0.01
-4.71 -0.53 -1.10 -3.80 -4.17 -5.66 -3.78 -1.16 -0.13
-3.89 -0.53 -1.10 -3.79 -4.17 -5.35 -3.28 -0.91 0.02

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?